M&A Deal Summary

Perrigo Company Acquires Fera Pharmaceuticals - Ophthalmic Ointments

On June 17, 2013, Perrigo Company acquired healthcare services company Fera Pharmaceuticals - Ophthalmic Ointments from Fera Pharmaceuticals for 93M USD

Acquisition Highlights
  • This is Perrigo Company’s 2nd transaction in the Healthcare Services sector.
  • This is Perrigo Company’s 12th largest (disclosed) transaction.
  • This is Perrigo Company’s 12th transaction in the United States.
  • This is Perrigo Company’s 1st transaction in New York.

M&A Deal Summary
Date 2013-06-17
Target Fera Pharmaceuticals - Ophthalmic Ointments
Sector Healthcare Services
Buyer(s) Perrigo Company
Sellers(s) Fera Pharmaceuticals
Deal Type Divestiture
Deal Value 93M USD

Target

Fera Pharmaceuticals - Ophthalmic Ointments

Melville, New York, United States
Fera Pharmaceuticals - Ophthalmic Ointments is a provider of anti-infective ophthalmic drugs.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Perrigo Company

Dublin 2, Ireland
Category Company
Founded 1887
Sector Life Science
Employees9,140
Revenue 4.7B USD (2023)
DESCRIPTION
Entrance to a Perrigo facility in Duncan, South Carolina.
Entrance to a Perrigo facility in Duncan, South Carolina.

Perrigo Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API), as well as receives royalties from Multiple Sclerosis drug Tysabri®. The company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market and an industry leader in pharmaceutical technologies. Perrigo Company was founded in 1887 and is based in Dublin, Ireland.

DEAL STATS #
Overall 19 of 31
Sector (Healthcare Services) 2 of 3
Type (Divestiture) 2 of 7
State (New York) 1 of 1
Country (United States) 12 of 18
Year (2013) 3 of 4
Size (of disclosed) 12 of 23
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-04-01 Velcera

Yardley, Pennsylvania, United States

Velcera, Inc. develops pet medicines in pain management, anti-allergy and parasiticides that can provide superior convenience and greater compliance than traditional products.

Buy $160M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-12-18 Elan

Dublin, Ireland

Elan is a biotechnology company, headquartered in Dublin, Ireland, committed to making a difference in the lives of patients and their families by dedicating itself to bringing innovations in science to fill significant unmet medical needs that continue to exist around the world. It focused on discovering and developing advanced therapies in neurodegenerative and autoimmune diseases.

Buy $8.6B

Seller(S) 1

SELLER

Fera Pharmaceuticals

Locust Valley, New York, United States
Category Company
Founded 2007
Sector Healthcare Services
DESCRIPTION

Fera Pharmaceuticals LLC is a specialty pharmaceutical company.

DEAL STATS #
Overall 1 of 1
Sector (Healthcare Services) 1 of 1
Type (Divestiture) 1 of 1
State (New York) 1 of 1
Country (United States) 1 of 1
Year (2013) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-07-16 Fera Pharmaceuticals - Ophthalmic Ointments

Melville, New York, United States

Fera Pharmaceuticals - Ophthalmic Ointments is a provider of anti-infective ophthalmic drugs.

Buy -
Mergr

Product

Company

Legal